Population-based assessment of cancer survivors' financial burden and quality of life: A prospective cohort study

Journal of Oncology Practice

Volumn 11, Issue 2, 2015, Pages 145-150

  Yousuf Zafar, S ^a   McNeil, Rebecca B ^a   Thomas, Catherine M ^a   Lathan, Christopher S ^a   Ayanian, John Z ^a   Provenzale, Dawn ^a  

^a DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVOR; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; INCOME; INTEGRATED HEALTH CARE SYSTEM; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; STRUCTURAL EQUATION MODELING; COLORECTAL NEOPLASMS; COST OF ILLNESS; ECONOMICS; LUNG NEOPLASMS; MIDDLE AGED; PERCEPTION; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SURVIVOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COST OF ILLNESS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PERCEPTION; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVIVORS;

EID: 84925333002     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2014.001542     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention: Burden of medical care cost: Early release of estimates from the national health interview survey, January-June 2011. www.cdc.gov/nchs/nhis/releases.htm
2. Kaiser Family Foundation: Employer health benefits, 2013 annual survey. http://kaiserfamilyfoundation.files.wordpress.com/2013/08/8465-employer-health-benefits-20131.pdf
3. Agency for Healthcare Research and Quality: Top 10 most costly conditions among men and women, 2008: Estimates for the U.S. civilian noninstitutionalized adult population, age 18 and older. http://meps.ahrq.gov/mepsweb/data-files/publications/st331/stat331.shtml
4. Bernard DS, Farr SL, Fang Z: National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 29: 2821-2826, 2011
5. Ramsey S, Blough D, Kirchhoff A, et al: Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff 32:1143-1152, 2013
6. Zafar SY, Peppercorn JM, Schrag D, et al: The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 18:381-390, 2013
7. Shankaran V, Jolly S, Blough D, et al: Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol 30:1608-1614, 2012
8. Guy GP Jr, Ekwueme DU, Yabroff KR, et al: Economic burden of cancer survivorship among adults in the united states. J Clin Oncol 31:3749-3757, 2013
9. Streeter SB, Schwartzberg L, Husain N, et al: Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract 7:46s-51s, 2011
10. Neugut AI, Subar M, Wilde ET, et al: Association between prescription copayment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29:2534-2542, 2011
11. Ayanian JZ, Chrischilles EA, Fletcher RH, et al: Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22:2992-2996, 2004
12. Cancer Care Outcomes Research and Surveillance Consortium: Protocol and instruments requests. https://www.cancors.org/public/pub
13. Malin JL, Ko C, Ayanian JZ, et al: Understanding cancer patients' experience and outcomes: Development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 14:837-848, 2006
14. Cella D, Li JZ, Cappelleri JC, et al: Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: Results from a phase III randomized trial. J Clin Oncol 26:3763-3769, 2008
15. Piccirillo JF, Tierney RM, Costas I, et al: Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441-2447, 2004
16. Kline RB: Principles and Practice of Structural Equation Modeling. New York, NY, Guilford Press, 2011
17. Tu YK: Commentary: Is structural equation modelling a step forward for epidemiologists? Int J Epidemiol 38:549-551, 2009
18. VanderWeele TJ: Invited commentary: Structural equation models and epidemiologic analysis. Am J Epidemiol 176:608-612, 2012
19. Kupek E: Beyond logistic regression: Structural equations modelling for binary variables and its application to investigating unobserved confounders. BMC Med Res Methodol 6:13, 2006
20. Fenn KM, Evans SB, McCorkle R, et al: Impact of financial burden of cancer on survivors' quality of life. J Oncol Pract 10:332-338, 2014
21. Dusetzina SB, Winn AN, Abel GA, et al: Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 32:306-311, 2014
22. De Boer AG, Taskila T, Ojajärvi A, et al: Cancer survivors and unemployment: A meta-analysis and meta-regression. JAMA 301:753-762, 2009
23. Lauzier S, Maunsell E, Drolet M, et al: Wage losses in the year after breast cancer: Extent and determinants among Canadian women. J Natl Cancer Inst 100:321-332, 2008
24. Kent EE, Forsythe LP, Yabroff KR, et al: Are survivors who report cancer-related financial problems more likely to forego or delay medical care? Cancer 119:3710-3717, 2013
25. Earle CC, Chretien Y, Morris C, et al: Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol 28:1700-1705, 2010
26. de Souza JA, Yap BJ, Hlubocky FJ, et al: The development of a financial toxicity patient-reported outcome in cancer: The cost measure. Cancer 120:3245-3253, 2014
27. Smith SK, Nicolla J, Zafar SY: Bridging the gap between financial distress and available resources for patients with cancer: A qualitative study. J Oncol Pract 10:e368-e372, 2014
28. Hibbard JH, Greene J, Overton V: Patients with lower activation associated with higher costs; delivery systems should know their patients' 'scores'. Health Aff 32:216-222, 2013
29. Wu S-J, Sylwestrzak G, Shah C, et al: Price transparency for MRIS increased use of less costly providers and triggered provider competition. Health Aff 33:1391-1398, 2014
30. Bestvina CM, Zullig LL, Rushing C, et al: Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract 10:162-167, 2014
31. Asparouhov T: Bidirectional association. www.statmodel.com/download/Rec.pdf
32. Catalano PJ, Ayanian JZ, Weeks JC, et al: Representativeness of participants in the Cancer Care Outcomes Research and Surveillance Consortium relative to the Surveillance, Epidemiology, and End Results program. Med Care 51:e9-e15, 2013
33. Fischer KE, Stollenwerk B, Rogowski WH: Link between process and appraisal in coverage decision: An analysis with structural equation modeling. Med Decis Making 33:1009-1025, 2013
34. Ubel PA, Abernethy AP, Zafar SY: Full disclosure-out-of-pocket costs as side effects. N Engl J Med 369:1484-1486, 2013